ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹2,165 Cr | ₹1,796 Cr | ₹984 Cr | ₹1,646 Cr | ₹1,585 Cr |
What is the latest Consolidated Net Profit of ALKEM LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹2,165 Cr |
Mar2024 | ₹1,796 Cr |
Mar2023 | ₹984 Cr |
Mar2022 | ₹1,646 Cr |
Mar2021 | ₹1,585 Cr |
How is Consolidated Net Profit of ALKEM LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹2,165 Cr | 20.59 | |
Mar2024 | ₹1,796 Cr | 82.47 | |
Mar2023 | ₹984 Cr | -40.19 | |
Mar2022 | ₹1,646 Cr | 3.82 | |
Mar2021 | ₹1,585 Cr | - |
Compare Consolidated Net Profit of peers of ALKEM LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALKEM LABORATORIES | ₹63,628.4 Cr | 1.4% | 9.1% | -14.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹379,191.0 Cr | 1% | -0.9% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,973.0 Cr | -1.6% | -1.8% | 17.9% | Stock Analytics | |
CIPLA | ₹124,507.0 Cr | -1.8% | 3.7% | -6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,175.0 Cr | 0.7% | 2.4% | 3.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,355.0 Cr | -0.6% | 4.5% | -6.5% | Stock Analytics |
ALKEM LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALKEM LABORATORIES | 1.4% |
9.1% |
-14.1% |
SENSEX | 0.5% |
0.1% |
-2.1% |
You may also like the below Video Courses